📚 PASS Investment Adviser (Level 1) Difficulty: Beginner ℹ️ Info   ~5 min read
📌 Chapter 6.1 — Nature and Definition of Primary Markets

Imagine you are drafting an equity research note on a mid-cap manufacturing firm that has recently announced a rights issue to fund a debt-reduction plan. While browsing the corporate action calendar, you notice the company has set a record date for existing shareholders to subscribe to new equity at a significant discount to the prevailing market price.

As an analyst, your immediate task is to determine whether this move is a strategic deleveraging event that will improve long-term return on equity (ROE) or a desperate move to raise cash that signals operational distress. Calculating the theoretical ex-rights price (TERP) becomes your primary tool to assess the immediate impact on shareholder value.

A rights issue is fundamentally an invitation to existing shareholders to purchase additional shares in proportion to their current holdings. Unlike a fresh public issue, which targets the broader market, a rights issue preserves the existing ownership structure and prevents immediate dilution of control for those who choose to subscribe. From a valuation perspective, the ‘discount’ offered is not a free lunch; it is mathematically balanced by the dilution of the existing share base.

Understanding this mechanism is vital because your valuation model must account for the increase in share count and the corresponding change in earnings per share (EPS) post-issuance.

Consider a case where a company with 1 million shares priced at ₹500 offers a 1-for-4 rights issue at ₹300. The market value of the company before the issue is ₹500 million, and the company will raise an additional ₹75 million by issuing 0.25 million new shares. The new total market capitalization will be ₹575 million across 1.25 million shares, resulting in a theoretical price of ₹460.

Your recommendation must weigh whether the capital injection yields a return on invested capital (ROIC) higher than the cost of equity, which is the ultimate test of whether the rights issue creates or destroys long-term shareholder wealth.

Furthermore, the ‘renunciation’ feature in Indian markets adds another layer of complexity for institutional portfolios. If a fund decides not to subscribe, it can sell its ‘rights entitlement’ in the market, effectively monetizing the value of the option. As an analyst, recognizing whether these rights are being traded at a premium or discount provides a sentiment indicator regarding how the market perceives the company’s future growth prospects. Analyzing the take-up rate of these rights is a classic litmus test for management credibility and shareholder loyalty.1

Nuance

⚠️ Nuance
Candidates often mistakenly believe that a rights issue at a discount automatically harms current shareholders. In reality, if the company utilizes the capital for high-NPV projects, the post-issue share price may actually appreciate, offsetting the dilution effect. The confusion typically stems from equating a share price drop—which is an accounting necessity post-record date—with a decline in the fundamental value of the investment.

Check Your Understanding

Practice Question 1

A company with 2,000,000 shares currently trading at ₹400 announces a 1-for-5 rights issue at a price of ₹250. What is the Theoretical Ex-Rights Price (TERP)?

Practice Question 2

Which of the following describes the ‘renunciation’ of rights in an Indian market context?

This is a companion read for Section 6.1 — Nature and Definition of Primary Markets from PASS Investment Adviser (Level 1) by Akhilesh Gururani, available on Amazon Kindle.

Copyright © 2026 HABSG Consulting

  1. The Theoretical Ex-Rights Price (TERP) is calculated as: [(Existing Shares × Market Price) + (New Shares × Issue Price)] / (Total Shares after Issue). ↩︎